Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple Sclerosis
- Sponsor
- Comenius University
- Study ID
- NCT07786506
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Multiple Sclerosis
- Muscle Spasticity
- Neuropathic Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Active Intermittent Theta-Burst Stimulation (iTBS) — DEVICEActive iTBS will be delivered using a Neuro-MS/D Advanced Therapeutic magnetic stimulator (Neurosoft) with a figure-of-eight coil. The stimulation target will be the representation of the muscle group corresponding to the dominant spastic pattern of the more affected lower limb in the contralateral primary motor cortex. The target will be identified using motor-evoked potentials and neuronavigation based on the participant's individual MRI. Active motor threshold will be determined from the tibialis anterior muscle. Stimulation intensity will be set at 80% of the active motor threshold. Each burst will consist of 3 pulses at 50 Hz, repeated at 5 Hz. Each 600-pulse block will use a 2-second on/8-second off pattern and last approximately 3 minutes 9 seconds. Two 600-pulse blocks will be delivered per day, separated by a 15-minute interval, for a total of 1,200 pulses per day. Treatment will be administered on five consecutive weekdays, giving 10 stimulation blocks in total.
- Sham Intermittent Theta-Burst Stimulation — DEVICEIn both groups, the TMS coil will be positioned over the primary motor cortex representation of the more affected lower limb and sham electrodes will be attached to the forehead. During sham stimulation, surface electrodes placed on the forehead will deliver low-intensity electrical stimulation at 2 mA to reproduce the somatosensory experience of TMS. The TMS device will simultaneously produce the characteristic clicking sound of coil discharge. The software will conceal the assigned mode from the participant and stimulation operator. The visit schedule, positioning, and total procedural duration will match the active condition.
Study Details
Spasticity and neuropathic pain are frequent and disabling symptoms of multiple sclerosis. Intermittent theta-burst stimulation (iTBS) is a non-invasive neuromodulation technique that may modulate cortical and corticospinal excitability and thereby improve motor symptoms and pain. This randomized, parallel-group, sham-controlled, assessor-blinded study will evaluate the clinical efficacy of active iTBS compared with sham stimulation in adults with multiple sclerosis and clinically significant lower-limb spasticity and pain. Participants will receive five stimulation sessions over one week. Spasticity, pain, patient-reported outcomes, and the electrophysiological H/M ratio will be assessed at baseline and at Weeks 2 and 4 after the intervention.
Key Dates
- First listed
- Aug 26, 2026
- Start date
- Aug 10, 2026
- Status verified
- Aug 2026
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: active iTBSParticipants will receive active intermittent theta-burst stimulation over the primary motor cortex contralateral to the more affected lower limb.
- Sham Comparator: sham iTBSParticipants will receive sham stimulation over the same cortical target and according to the same visit schedule as the active group.
Primary Outcome Measure
The Modified Tardieu Scale Quality of Muscle Reaction Score [ Time Frame: Baseline, Week 2, and Week 4 after the final stimulation session ]
Central Contacts
- Karolína Lisá, MD+421 2 5954 2297
- Jaroslav Meluš, MD, PhD.+421 2 5954 2297
Find similar trials
Related Studies
- Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)Recruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- NARCOMS Registry: A Multiple Sclerosis RegistryRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas